Antioxidant Selenium Offers No Heart-Disease ProtectionApril 26, 2006BUFFALO, N.Y. - Selenium does not protect against cardiovascular disease, despite its documented antioxidant and chemopreventive properties, analysis of a randomized placebo-controlled clinical trial covering 13 years has shown. The selenium-CVD association was a secondary endpoint in the Nutritional Prevention of Cancer Trial, which was designed primarily to determine if selenium supplementation could prevent the recurrence of non-melanoma skin cancer. Results of the trial, the only large randomized clinical trial to date to examine selenium supplementation alone in the prevention of CVD, appear in the April 15 issue of the American Journal of Epidemiology. Saverio Stranges, M.D., Ph.D., assistant professor of social and preventive medicine in the School of Public Health and Health Professions, University at Buffalo, is first author.
"Our results extend previous research based on smaller intervention trials focusing on cardiovascular risk factors," said Stranges. "Our findings are consistent with those from previous studies that have shown no beneficial effect of selenium supplementation in combination with other antioxidants on the primary prevention of cardiovascular disease." Several antioxidants, vitamins C and E in particular, that were thought to play a role in preventing heart disease based on observational studies have turned out not to be protective in randomized clinical trials, and selenium now has joined this group. The main findings of this report focus on the 1,004 participants in the study, conducted from 1983-96, who were free of cardiovascular disease when they were recruited. Participants came from seven dermatology clinics in low selenium areas of the eastern United States: Augusta and Macon, Ga.; Columbia, S.C.; Miami, Fla.; Wilson and Greenville, N. C.; and Newington, Conn. Enrollees were assigned randomly to take a tablet containing 200 micrograms of selenium daily or a placebo. Information on sociodemographics, health habits, education and body mass index also was collected. Participants provided blood samples at their respective clinics twice a year and reported any new illnesses or medications. Individuals were followed for an average of 7.6 years. Results showed no association between selenium supplementation on any of the endpoints studied: coronary heart disease, stroke or deaths from cardiovascular disease, Stranges said. There also was no difference in the endpoints based on the level of selenium at baseline. In addition, the lack of significant association with CVD endpoints was confirmed even in the 246 participants who had CVD at baseline. (This data does not appear in the published manuscript.) "These results must be interpreted cautiously," said Stranges, "because they result from exploratory analyses, although from the largest randomized clinical trial available that has selenium only as the intervention. However, this report adds important information to our knowledge on the role of selenium in cardiovascular-disease prevention, indicating no overall benefit of supplementation by selenium alone in prevention of cardiovascular disease." Additional contributors to the study were James R. Marshal, Ph.D., Raj Natarajan and Mary E. Reid, Ph.D., from Roswell Park Cancer Institute in Buffalo; Maurizio Trevisan, M.D., and Richard P. Donahue, M.P.H., Ph.D., of the UB School of Public Health and Health Professions; Gerald F. Combs, Jr., Ph.D., from the USDA Human Nutrition Research Center in Grand Forks, N.D.; Eduardo Farinaro, M.D., of "Federico II" University of Naples Medical School, Naples, Italy, and the late Larry C. Clark, M.P.H., Ph.D., a major contributor to research on selenium and prostate cancer. The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. The University at Buffalo | |||||||||||||||||||||
|
Related Selenium Current Events and Selenium News Articles How do the choline compounds change when apoptosis occurs? Apoptosis is a programmed, active, highly selective mechanism of cell death. Abnormal regulation of apoptosis can lead to disorders such as cancer. The field of apoptosis research has undergone an explosion of new knowledge over the past decade. Coating copies microscopic biological surfaces Someday, your car might have the metallic finish of some insects or the deep black of a butterfly's wing, and the reflectors might be patterned on the nanostructure of a fly's eyes. New mushroom study shows the power of energy density Preliminary research, led by Dr. Lawrence Cheskin, MD, Director of John Hopkins Weight Management Center, suggests increasing intake of low-energy density foods, specifically mushrooms, in place of high-energy-density foods, like lean ground beef, is a strategy for preventing or treating obesity. Toxic to aliens -- but key to health of planet Scientists at the University of Leicester are using an ingredient found in common shampoos to investigate how the oxygen content of the oceans has changed over geologically recent time. Microwave synthesis connects with the (quantum) dots Materials researchers at the National Institute of Standards and Technology (NIST) have developed a simplified, low-cost process for producing high-quality, water-soluble "quantum dots" for biological research. Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online. Supplements are not nutritious Selenium supplementation, for example in mineral tablets, might not be that beneficial for the majority of people according to researchers writing in the open access journal Genome Biology. Ways to improve informed consent are testable, study says New ways to make sure people are adequately informed about the risks and benefits of taking part in a clinical trial can be field-tested for effectiveness as vigorously as new medical treatments themselves, a study led by a Johns Hopkins bioethicist suggests. Scientists compare 12 fruit fly genomes An international research consortium of scientists, supported by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced publications comparing the genome sequences of 12 closely related fruit fly species, 10 of which were sequenced for the first time. Higher levels of pollutants found in fish caught near a coal-fired power plant Emissions from coal-fired power plants may be an important source of water pollution and fish contamination. More Selenium Current Events and Selenium News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||